When standard chemotherapy wasn’t working for one patient, a blend of two remarkable therapies – CAR-T and CRISPR – trained the immune system to exterminate the cancer. Guests include patient Katie Kopp and Dr. Joseph McGuirk, hematologist and medical oncologist and the Division Director of Hematologic Malignancies and Cellular Therapeutics at The University of Kansas Cancer Center.